Skip to main content
SpringerLink
Log in

Traditional Chinese medicine for modern treatment of Parkinson’s disease

  • Review
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Parkinson’s disease (PD) is a chronic and progressive degenerative disorder of brain commonly seen among the elderly. As conventionally medical therapy is of limited relief and potential side effects, complementary and alternative medicine (CAM) has attracted growing public and professional attention. Therapies such as acupuncture, musical/rhythmic therapy and deep brain stimulation have been gradually proved positively in clinic. In this review, we retrospected the scientifific or evidence-based-medicine advances of application and research for modern treatment of PD by CAM, especially traditional Chinese medicine in categories.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wang XP, Chen HZ. Thematic selection: strategies of current drugs and alternative treatments for neurodegenerative diseases. Curr Neuropharmacol 2016;14:301–302.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Staud R. Effectiveness of CAM therapy: understanding the evidence. Rheum Dis Clin North Am 2011;37:9–17.

    Article  PubMed  Google Scholar 

  3. Lökk J, Nilsson M. Frequency, type and factors associated with the use of complementary and alternative medicine in patients with Parkinson’s disease at a neurological outpatient clinic. Parkinsonism Relat Disord 2010;16:540–544.

    Article  PubMed  Google Scholar 

  4. Shulman LM, Wen X, Weiner WJ, Bateman D, Minagar A, Duncan R, et al. Acupuncture therapy for the symptoms of Parkinson’s disease. Mov Disord 2002;17:799–802.

    Article  PubMed  Google Scholar 

  5. Schober A. Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP. Cell Tissue Res 2004;318:215–224.

    Article  PubMed  Google Scholar 

  6. Fahn S. Parkinson’s disease: 10 years of progress, 1997–2007. Mov Disord 2010;25(Suppl 1):S2–S14.

    Article  PubMed  Google Scholar 

  7. Yang JL, Chen JSC, Yang YF, Chen JC, Lin CH, Chang RS, et al. Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson’s disease mice. Brain Behav Immun 2011;25:1452–1459.

    Article  CAS  PubMed  Google Scholar 

  8. Yeo S, Choi YG, Hong YM, Lim S. Neuroprotective changes of thalamic degeneration-related gene expression by acupuncture in an MPTP mouse model of parkinsonism: microarray analysis. Gene 2013;515:329–338.

    Article  CAS  PubMed  Google Scholar 

  9. Doisson TD, Wieloch T, Diano S, Warden CH, Horvath TL, Mattiasson G. Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse. J Cereb Blood Flow Meta 2008;28:1186–1195.

    Article  Google Scholar 

  10. Yu YP, Ju WP, Li ZG, Wang DZ, Wang YC, Xie AM. Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat. Brain Res 2010;1336:58–65.

    Article  CAS  PubMed  Google Scholar 

  11. Yin H, Nichols TD, Horowitz JM. Transcription of mouse Sp2 yields alternatively spliced and sub-genomic mRNAs in a tissue-and cell-type-specific fashion. Biochim Biophys Acta 2010;1799:520–531.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Phan D, Cheng CJ, Galfione M, Vakar-Lopez F, Tunstead J, Thompson NE, et al. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigenrelated cell adhesion molecule 1 in tumorigenesis. Cancer Res 2004;64:3072–3078.

    Article  CAS  PubMed  Google Scholar 

  13. Al-Mutairi MS, Cadalbert LC, McGachy HA, Shweash M, Schroeder J, Kurnik M, et al. MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana. PLoS pathogens 2010;6:e1001192.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Choi YG, Yeo S, Hong YM, Lim S. Neuroprotective changes of striatal degeneration-related gene expression by acupuncture in an MPTP mouse model of Parkinsonism: microarray analysis. Cell Mol Neurobio 2011;31:377–391.

    Article  Google Scholar 

  15. Kim ST, Moon W, Chae Y, Kim YJ, Lee H, Park HJ. The effect of electro-acupuncture for 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced proteomic changes in the mouse striatum. J Physiol Sci 2010;60:27–34.

    Article  CAS  PubMed  Google Scholar 

  16. Chae Y, Lee H, Kim H, Kim CH, Chang DI, Kim KM, et al. Parsing brain activity associated with acupuncture treatment in Parkinson’s diseases. Mov Disord 2009;24:1794–1802.

    Article  PubMed  Google Scholar 

  17. Shen X, Xie YY, Chen C, Wang XP. Effects of electroacupuncture on cognitive function in rats with Parkinson’s disease. Int J Physiol Pathophysiol Pharmacol 2015;7:145–151.

    PubMed  PubMed Central  Google Scholar 

  18. Lam YC, Kum WF, Durairajan SSK, Lu JH, Man SC, Xu M, et al. Efficacy and safety of acupuncture for idiopathic Parkinson’s disease: a systematic review. J Altern Complement Med 2008;14:663–671.

    Article  PubMed  Google Scholar 

  19. Kim HJ, Jeon BS. Is acupuncture efficacious therapy in Parkinson’s disease? J Neurol Sci 2014;341:1–7.

    Article  PubMed  Google Scholar 

  20. Lee MS, Shin BC, Kong JC, Ernst E. Effectiveness of acupuncture for Parkinson’s disease: a systematic review. Mov Disord 2008;23:1505–1515.

    Article  PubMed  Google Scholar 

  21. Chen LW, Wang YQ, Wei LC, Shi M, Chan YS. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinsons disease. CNS Neurol Disord Drug Targets 2007;6:273–281.

    Article  CAS  PubMed  Google Scholar 

  22. Wang DM, Hai JR, Wei F. Influence of Paning Decoction on non-motor symptoms in Parkinson’s disease. Tradit Chin Drug Res Clin Pharm (Chin) 2012;23:353–356.

    Google Scholar 

  23. Zhao GH, Sun F, Feng XG. Treatment of non-motor symptoms of Parkinson’s disease patients of Gan-Shen deficiency syndrome by Guling Pa’an Granule: a multicenter double-blinded randomized controlled trial. Chin J Integr Tradit West Med (Chin) 2013;33:476–479.

    Google Scholar 

  24. Sun HM, Bai LM, Zhang J. Effects of Yinxing Pingchan Recipe and its components on activity of mitochondrial enzyme complex in brain of mice with Parkinson’s disease. Chin J Integr Tradit West Med (Chin) 2005;25:1008–1011.

    Google Scholar 

  25. Pan T, Fei J, Zhou X, Jankovic J, Le W. Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury. Life Sci 2003;72:1073–1083.

    Article  CAS  PubMed  Google Scholar 

  26. Mandel S, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T, et al. Multifunctional activities of green tea catechins in neuroprotection. Neurosignals 2005;14:46–60.

    Article  CAS  PubMed  Google Scholar 

  27. Choi JY, Park CS, Kim DJ, Cho MH, Jin BK, Pie JE, et al. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson’s disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology 2002;23:367–374.

    Article  CAS  PubMed  Google Scholar 

  28. Chen Y, Chen XC. Possible mechanisms of the protective effect of ginsenoside Rg1 on apoptosis in substantia nigra neurons. Acta Pharm Sin (Chin) 2002;37:249–252.

    CAS  Google Scholar 

  29. Wu WR, Zhu XZ. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sci 1999;65:157–161.

    Article  CAS  PubMed  Google Scholar 

  30. Li X, Matsumoto K, Murakami Y, Tezuka Y, Wu Y, Kadota S. Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice. Pharm Biochem Behav 2005;82:345–352.

    Article  CAS  Google Scholar 

  31. Chan YC, Wang MF, Chen YC, Yang DY, Lee MS, Cheng FC. Long-term administration of Polygonum multiflorum Thunb: reduces cerebral ischemia-induced infarct volume in gerbils. Am J Chin Med 2003;31:71–77.

    Article  PubMed  Google Scholar 

  32. Feng JJ, Li YL, Hou C. The neuron-protective effect of ginkgo biloba extract on rat models of Parkinson’s disease. J Xi’an Jiaotong Univ (Med Sci, Chin) 2011;32:783–786.

    CAS  Google Scholar 

  33. Nie G, Jin C, Cao Y, Shen S, Zhao B. Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch Biochem Biophys 2002;397:84–90.

    Article  CAS  PubMed  Google Scholar 

  34. Chen Y, Fang F, Shen S, Zhao B. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol Sin 2005;26:56–62.

    Article  PubMed  Google Scholar 

  35. Gagne JJ, Power MC. Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 2010;74:995–1002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Li WJ, Wang JF, Wang XP. Wilson’s disease: update on integrated Chinese and Western medicine. Chin J Integr Med 2013;19:233–240.

    Article  PubMed  Google Scholar 

  37. Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, et al. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 2003;17:1943–1944.

    CAS  PubMed  Google Scholar 

  38. Dajas F, Rivera F, Blasina F, Arredondo F, Echeverry C, Lafon L, et al. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotoxicity Res 2003;5:425–432.

    Article  Google Scholar 

  39. Lin YL, Lin JK. (–)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-κB. Mol Pharm 1997;52:465–472.

    CAS  Google Scholar 

  40. Lee MM, Huang HM, Hsieh MT, Chen CS, Yeh FT, Kuo JS. Anti-inflammatory and neuroprotective effects of magnolol in chemical hypoxia in rat cultured cortical cells in hypoglycemic media. Chin J Physio (Chin) 2000;43:61–68.

    CAS  Google Scholar 

  41. Bao YC, Fang X, Zhang B. Effect of Chinese herbal medicine on the immune response of Parkinson’s disease rat model. Clin J Chin Med Pharm (Chin) 2005;17:360–362.

    Google Scholar 

  42. Li G, Ma R, Xu Y. Protective effects of triptolide on the lipopolysaccharide-mediated degeneration of dopaminergic neurons in substantia nigra. Chin J Integr Tradit West Med (Chin) 2006;26:715–718.

    CAS  Google Scholar 

  43. He JC, Yuan CX, Wei HC, Chen RX. Effect of Chinese and Western medicine integration on spinning behavior of rats with Parkinson disease. J Chin Integr Med (Chin) 2003;1:293–295.

    Article  Google Scholar 

  44. Kim SD, Allen NE, Canning CG, Fung VS. Postural instability in patients with Parkinson’s disease. CNS Drugs 2013;27:97–112.

    Article  PubMed  Google Scholar 

  45. Low S, Ang L W, Goh K S, Chew SK. A systematic review of the effectiveness of Tai Chi on fall reduction among the elderly. Arch Gerontol Geriatr 2009;48:325–331.

    Article  PubMed  Google Scholar 

  46. Hackney ME, Earhart GM. Health-related quality of life and alternative forms of exercise in Parkinson disease. Parkinsonism Relat Disord 2009;15:644–648.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Wang XP, Sun BM, Ding HL. Changes of procedural learning in Chinese patients with non-demented Parkinson disease. Neurosci Lett 2009;449:161–163.

    Article  CAS  PubMed  Google Scholar 

  48. Wang WC, Zhang AL, Rasmussen B, Lin LW, Dunning T, Kang SW, et al. The effect of Tai Chi on psychosocial wellbeing: a systematic review of randomized controlled trials. J Acupunct Meridi Stud 2009;2:171–181.

    Article  Google Scholar 

  49. Zhang LL, Canning SD, Wang XP. Freezing of gait in Parkinsonism and its potential drug treatment. Curr Neuropharmacol 2016;14:302–306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Li F, Harmer P, Fitzgerald K, Eckstrom E, Stock R, Galver J, et al. Tai Chi and postural stability in patients with Parkinson’s disease. N Engl J Med 2012;366:511–519.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Shanghai Tong-Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China

    Lu Han, Yuan-hong Xie, Rong Wu, Chen Chen, Yan Zhang & Xiao-ping Wang

Authors
  1. Lu Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuan-hong Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiao-ping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiao-ping Wang.

Additional information

Supported by National Natural Science Foundation of China (No. 81071065 and No. 81671103)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, L., Xie, Yh., Wu, R. et al. Traditional Chinese medicine for modern treatment of Parkinson’s disease. Chin. J. Integr. Med. 23, 635–640 (2017). https://doi.org/10.1007/s11655-016-2537-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-016-2537-7

Keywords

Search

Navigation